发明名称 METHODS FOR THE TREATMENT OF MITOCHONDRIAL DISEASE
摘要 The disclosure provides methods of preventing, ameliorating or treating disruption of mitochondrial function and symptoms thereof. The methods provide administering aromatic-cationic peptides in effective amounts to prevent, treat or ameliorate the disruption of mitochondrial oxidative phosphorylation in a cell such as that found in a subject suffering from, or predisposed to a mitochondrial disease or disorder. In some embodiments, the methods comprise administering to a subject suffering from, or at risk for a mitochondrial disease or disorder, an effective amount of an aromatic-cationic peptide to subjects in need thereof.
申请公布号 US2016002293(A1) 申请公布日期 2016.01.07
申请号 US201414771411 申请日期 2014.02.28
申请人 STEALTH BIOTHERAPEUTICS CORP. 发明人 Wilson D. Travis
分类号 C07K5/11 主分类号 C07K5/11
代理机构 代理人
主权项 1. A method for treating a mammalian cell with a disruption of mitochondrial oxidative phosphorylation, wherein the disruption of mitochondrial oxidative phosphorylation is associated with at least one gene mutation, the method comprising: contacting the cell with a therapeutically effective amount of the peptide D-Arg-2′,6′-Dmt-Lys-Phe-NH2 or a pharmaceutically acceptable salt thereof, thereby treating or ameliorating the disruption of oxidative phosphorylation in the cell.
地址 Monoco MC